Albireo to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 13, 2018
BOSTON, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that its third quarter financial results will be reported on …